Diabetic Ketoacidosis: Possible Cause of Thrombotic Thrombocytopenic Purpura.

Division

South Atlantic

Hospital

Grand Strand Medical Center

Document Type

Case Report

Publication Date

9-16-2021

Keywords

adamts13, coagulopathy, diabetic ketoacidosis, microangiopathy, microscopic hemolytic anemia, plasma exchange, thrombotic thrombocytopenic purpura

Disciplines

Endocrine System Diseases | Endocrinology, Diabetes, and Metabolism | Internal Medicine

Abstract

Acquired thrombotic thrombocytopenic purpura (TTP) is an uncommon microangiopathic disorder that can have variable presentations and can be precipitated by a multitude of stressors to the body, most commonly sepsis. TTP is caused by a deficiency of ADAMTS13 leading to intravascular clotting causing thrombocytopenia and microangiopathic hemolytic anemia. TTP can be associated with various other pathologic conditions. One such rare association has been reported with diabetic ketoacidosis (DKA). Here, we present an even less appreciated presentation in association with DKA. A 62-year-old African American male with previously diagnosed prediabetes presented with DKA and developed hemodynamically significant bleeding. He was confirmed to have TTP that responded to plasmapheresis. TTP is a life-threatening illness if not treated urgently with plasmapheresis with or without rituximab. As acquired TTP most commonly occurs during stress on the body, it is important to treat the underlying stressor. Early identification and initiation of appropriate interventions are crucial to reducing mortality associated with TTP. Furthermore, we need to appreciate less commonly associated conditions such as DKA among patients.

Publisher or Conference

Cureus

Share

COinS